Asymchem Laboratories (Tianjin) Co., Ltd.
Asymchem Laboratories (Tianjin) Co., Ltd. 6821.HK Peers
See (6821.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 6821.HK | HK$74.40 | +4.06% | 32.8B | 24.16 | HK$3.08 | +1.62% |
| 1801.HK | HK$77.35 | -6.13% | 129.8B | -1310.00 | -HK$0.06 | N/A |
| 2269.HK | HK$25.15 | +0.60% | 102.3B | 29.59 | HK$0.85 | N/A |
| 1177.HK | HK$5.30 | +2.51% | 94.8B | 48.18 | HK$0.11 | +10.37% |
| 9926.HK | HK$92.50 | -2.48% | 82.9B | -142.31 | -HK$0.65 | N/A |
| 1530.HK | HK$22.70 | +1.34% | 51.8B | 23.60 | HK$0.93 | +1.10% |
| 3759.HK | HK$15.94 | +2.31% | 43.2B | 13.86 | HK$1.15 | +1.48% |
| 9995.HK | HK$55.55 | -6.17% | 38B | -18.64 | -HK$2.98 | N/A |
| 1877.HK | HK$20.90 | -7.93% | 31.3B | -15.00 | -HK$1.42 | N/A |
| 1548.HK | HK$14.50 | -3.07% | 31.3B | -22.72 | -HK$0.64 | N/A |
Stock Comparison
6821.HK vs 1801.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 1801.HK has a market cap of 129.8B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 1801.HK trades at HK$77.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 1801.HK's P/E ratio is -1310.00. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1801.HK's ROE of -0.01%. Regarding short-term risk, 6821.HK is more volatile compared to 1801.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2269.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2269.HK has a market cap of 102.3B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2269.HK trades at HK$25.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2269.HK's P/E ratio is 29.59. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2269.HK's ROE of +0.08%. Regarding short-term risk, 6821.HK is more volatile compared to 2269.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1177.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 1177.HK has a market cap of 94.8B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 1177.HK trades at HK$5.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 1177.HK's P/E ratio is 48.18. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1177.HK's ROE of +0.11%. Regarding short-term risk, 6821.HK is more volatile compared to 1177.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 9926.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 9926.HK has a market cap of 82.9B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 9926.HK trades at HK$92.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 9926.HK's P/E ratio is -142.31. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 9926.HK's ROE of -0.09%. Regarding short-term risk, 6821.HK is more volatile compared to 9926.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1530.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 1530.HK has a market cap of 51.8B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 1530.HK trades at HK$22.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 1530.HK's P/E ratio is 23.60. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1530.HK's ROE of +0.14%. Regarding short-term risk, 6821.HK is more volatile compared to 1530.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 3759.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 3759.HK has a market cap of 43.2B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 3759.HK trades at HK$15.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 3759.HK's P/E ratio is 13.86. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 3759.HK's ROE of +0.14%. Regarding short-term risk, 6821.HK is more volatile compared to 3759.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 9995.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 9995.HK has a market cap of 38B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 9995.HK trades at HK$55.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 9995.HK's P/E ratio is -18.64. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 9995.HK's ROE of -0.58%. Regarding short-term risk, 6821.HK is less volatile compared to 9995.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1877.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 1877.HK has a market cap of 31.3B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 1877.HK trades at HK$20.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 1877.HK's P/E ratio is -15.00. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1877.HK's ROE of -0.20%. Regarding short-term risk, 6821.HK is more volatile compared to 1877.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1548.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 1548.HK has a market cap of 31.3B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 1548.HK trades at HK$14.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 1548.HK's P/E ratio is -22.72. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1548.HK's ROE of -0.06%. Regarding short-term risk, 6821.HK is more volatile compared to 1548.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 9688.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 9688.HK has a market cap of 30.5B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 9688.HK trades at HK$27.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 9688.HK's P/E ratio is -14.08. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 9688.HK's ROE of -0.33%. Regarding short-term risk, 6821.HK is more volatile compared to 9688.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2696.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2696.HK has a market cap of 27.3B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2696.HK trades at HK$50.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2696.HK's P/E ratio is 30.45. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2696.HK's ROE of +0.29%. Regarding short-term risk, 6821.HK is more volatile compared to 2696.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2096.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2096.HK has a market cap of 27.2B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2096.HK trades at HK$11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2096.HK's P/E ratio is 34.38. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2096.HK's ROE of +0.10%. Regarding short-term risk, 6821.HK is more volatile compared to 2096.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 6855.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 6855.HK has a market cap of 26.9B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 6855.HK trades at HK$77.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 6855.HK's P/E ratio is -47.23. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 6855.HK's ROE of -0.79%. Regarding short-term risk, 6821.HK is less volatile compared to 6855.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 9969.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 9969.HK has a market cap of 19.9B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 9969.HK trades at HK$13.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 9969.HK's P/E ratio is -47.50. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 9969.HK's ROE of -0.06%. Regarding short-term risk, 6821.HK is more volatile compared to 9969.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1952.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 1952.HK has a market cap of 18.3B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 1952.HK trades at HK$57.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 1952.HK's P/E ratio is -15.89. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1952.HK's ROE of -0.24%. Regarding short-term risk, 6821.HK is more volatile compared to 1952.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2162.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2162.HK has a market cap of 13.6B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2162.HK trades at HK$46.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2162.HK's P/E ratio is -21.51. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2162.HK's ROE of -0.20%. Regarding short-term risk, 6821.HK is more volatile compared to 2162.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2171.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2171.HK has a market cap of 13.3B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2171.HK trades at HK$23.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2171.HK's P/E ratio is -14.71. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2171.HK's ROE of +0.00%. Regarding short-term risk, 6821.HK is more volatile compared to 2171.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 6826.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 6826.HK has a market cap of 11.7B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 6826.HK trades at HK$24.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 6826.HK's P/E ratio is 12.60. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 6826.HK's ROE of +0.07%. Regarding short-term risk, 6821.HK is more volatile compared to 6826.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2157.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2157.HK has a market cap of 9.5B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2157.HK trades at HK$5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2157.HK's P/E ratio is -22.12. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2157.HK's ROE of -0.51%. Regarding short-term risk, 6821.HK is more volatile compared to 2157.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1672.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 1672.HK has a market cap of 8.8B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 1672.HK trades at HK$8.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 1672.HK's P/E ratio is -27.58. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1672.HK's ROE of -0.15%. Regarding short-term risk, 6821.HK is less volatile compared to 1672.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2315.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2315.HK has a market cap of 8.7B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2315.HK trades at HK$22.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2315.HK's P/E ratio is 251.67. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2315.HK's ROE of -0.19%. Regarding short-term risk, 6821.HK is more volatile compared to 2315.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1477.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 1477.HK has a market cap of 8.6B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 1477.HK trades at HK$10.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 1477.HK's P/E ratio is -24.47. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1477.HK's ROE of -0.08%. Regarding short-term risk, 6821.HK is more volatile compared to 1477.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 0775.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 0775.HK has a market cap of 8.3B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 0775.HK trades at HK$0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 0775.HK's P/E ratio is -86.00. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 0775.HK's ROE of -0.03%. Regarding short-term risk, 6821.HK is more volatile compared to 0775.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2142.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2142.HK has a market cap of 7B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2142.HK trades at HK$8.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2142.HK's P/E ratio is 275.67. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2142.HK's ROE of +0.02%. Regarding short-term risk, 6821.HK is less volatile compared to 2142.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2256.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2256.HK has a market cap of 6.9B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2256.HK trades at HK$10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2256.HK's P/E ratio is 252.50. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2256.HK's ROE of +0.01%. Regarding short-term risk, 6821.HK is more volatile compared to 2256.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 9966.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 9966.HK has a market cap of 5.9B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 9966.HK trades at HK$6.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 9966.HK's P/E ratio is 32.37. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 9966.HK's ROE of +0.10%. Regarding short-term risk, 6821.HK is more volatile compared to 9966.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2616.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2616.HK has a market cap of 5.7B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2616.HK trades at HK$4.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2616.HK's P/E ratio is -52.88. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2616.HK's ROE of -0.22%. Regarding short-term risk, 6821.HK is more volatile compared to 2616.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1541.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 1541.HK has a market cap of 4.7B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 1541.HK trades at HK$11.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 1541.HK's P/E ratio is -12.83. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1541.HK's ROE of -0.49%. Regarding short-term risk, 6821.HK is less volatile compared to 1541.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 6660.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 6660.HK has a market cap of 4.6B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 6660.HK trades at HK$3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 6660.HK's P/E ratio is -15.16. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 6660.HK's ROE of -0.08%. Regarding short-term risk, 6821.HK is more volatile compared to 6660.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2179.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2179.HK has a market cap of 3.8B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2179.HK trades at HK$7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2179.HK's P/E ratio is -6.26. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2179.HK's ROE of -0.82%. Regarding short-term risk, 6821.HK is more volatile compared to 2179.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2509.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2509.HK has a market cap of 3.3B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2509.HK trades at HK$15.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2509.HK's P/E ratio is -8.59. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2509.HK's ROE of -1.12%. Regarding short-term risk, 6821.HK is more volatile compared to 2509.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1167.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 1167.HK has a market cap of 3.3B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 1167.HK trades at HK$4.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 1167.HK's P/E ratio is -19.23. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1167.HK's ROE of -0.17%. Regarding short-term risk, 6821.HK is less volatile compared to 1167.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1873.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 1873.HK has a market cap of 3.1B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 1873.HK trades at HK$1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 1873.HK's P/E ratio is 21.43. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1873.HK's ROE of +0.04%. Regarding short-term risk, 6821.HK is more volatile compared to 1873.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2487.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2487.HK has a market cap of 2.9B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2487.HK trades at HK$9.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2487.HK's P/E ratio is -6.10. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2487.HK's ROE of -0.40%. Regarding short-term risk, 6821.HK is less volatile compared to 2487.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1521.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 1521.HK has a market cap of 2.3B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 1521.HK trades at HK$1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 1521.HK's P/E ratio is 56.50. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1521.HK's ROE of +0.00%. Regarding short-term risk, 6821.HK is more volatile compared to 1521.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 3681.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 3681.HK has a market cap of 2.3B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 3681.HK trades at HK$1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 3681.HK's P/E ratio is -10.05. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 3681.HK's ROE of -0.79%. Regarding short-term risk, 6821.HK is less volatile compared to 3681.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2181.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2181.HK has a market cap of 2B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2181.HK trades at HK$0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2181.HK's P/E ratio is -16.17. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2181.HK's ROE of -1.25%. Regarding short-term risk, 6821.HK is more volatile compared to 2181.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 6996.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 6996.HK has a market cap of 1.8B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 6996.HK trades at HK$2.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 6996.HK's P/E ratio is -5.23. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 6996.HK's ROE of -0.35%. Regarding short-term risk, 6821.HK is more volatile compared to 6996.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 6978.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 6978.HK has a market cap of 1.5B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 6978.HK trades at HK$2.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 6978.HK's P/E ratio is -7.46. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 6978.HK's ROE of -0.01%. Regarding short-term risk, 6821.HK is more volatile compared to 6978.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1875.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 1875.HK has a market cap of 1.5B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 1875.HK trades at HK$1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 1875.HK's P/E ratio is 38.20. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1875.HK's ROE of +0.05%. Regarding short-term risk, 6821.HK is more volatile compared to 1875.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2511.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2511.HK has a market cap of 1.4B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2511.HK trades at HK$2.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2511.HK's P/E ratio is -3.00. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2511.HK's ROE of -0.00%. Regarding short-term risk, 6821.HK is more volatile compared to 2511.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 6622.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 6622.HK has a market cap of 1.4B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 6622.HK trades at HK$2.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 6622.HK's P/E ratio is -5.34. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 6622.HK's ROE of -0.12%. Regarding short-term risk, 6821.HK is more volatile compared to 6622.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 6998.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 6998.HK has a market cap of 1.3B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 6998.HK trades at HK$2.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 6998.HK's P/E ratio is -22.09. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 6998.HK's ROE of -0.05%. Regarding short-term risk, 6821.HK is more volatile compared to 6998.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2137.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2137.HK has a market cap of 1.2B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2137.HK trades at HK$1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2137.HK's P/E ratio is -2.20. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2137.HK's ROE of -0.18%. Regarding short-term risk, 6821.HK is more volatile compared to 2137.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2126.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2126.HK has a market cap of 1.1B. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2126.HK trades at HK$2.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2126.HK's P/E ratio is -1.78. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2126.HK's ROE of -0.45%. Regarding short-term risk, 6821.HK is less volatile compared to 2126.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1244.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 1244.HK has a market cap of 982.6M. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 1244.HK trades at HK$4.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 1244.HK's P/E ratio is -4.89. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1244.HK's ROE of -0.22%. Regarding short-term risk, 6821.HK is more volatile compared to 1244.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2496.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2496.HK has a market cap of 949.9M. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2496.HK trades at HK$4.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2496.HK's P/E ratio is -8.91. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2496.HK's ROE of -3.00%. Regarding short-term risk, 6821.HK is more volatile compared to 2496.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2185.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2185.HK has a market cap of 836.7M. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2185.HK trades at HK$3.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2185.HK's P/E ratio is -9.10. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2185.HK's ROE of -0.13%. Regarding short-term risk, 6821.HK is more volatile compared to 2185.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 0690.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 0690.HK has a market cap of 667.2M. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 0690.HK trades at HK$0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 0690.HK's P/E ratio is 11.20. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 0690.HK's ROE of +0.26%. Regarding short-term risk, 6821.HK is more volatile compared to 0690.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 9939.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 9939.HK has a market cap of 651.3M. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 9939.HK trades at HK$1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 9939.HK's P/E ratio is -3.85. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 9939.HK's ROE of +0.00%. Regarding short-term risk, 6821.HK is more volatile compared to 9939.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 6628.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 6628.HK has a market cap of 623.7M. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 6628.HK trades at HK$1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 6628.HK's P/E ratio is -1.85. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 6628.HK's ROE of -0.35%. Regarding short-term risk, 6821.HK is more volatile compared to 6628.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2257.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2257.HK has a market cap of 483.8M. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2257.HK trades at HK$4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2257.HK's P/E ratio is -0.89. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2257.HK's ROE of +71.56%. Regarding short-term risk, 6821.HK is more volatile compared to 2257.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 2197.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 2197.HK has a market cap of 363.2M. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 2197.HK trades at HK$0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 2197.HK's P/E ratio is -0.35. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 2197.HK's ROE of +0.73%. Regarding short-term risk, 6821.HK is more volatile compared to 2197.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 8158.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 8158.HK has a market cap of 123.2M. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 8158.HK trades at HK$0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 8158.HK's P/E ratio is 6.75. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 8158.HK's ROE of +0.71%. Regarding short-term risk, 6821.HK is more volatile compared to 8158.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6821.HK.
6821.HK vs 1228.HK Comparison
6821.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6821.HK stands at 32.8B. In comparison, 1228.HK has a market cap of 119M. Regarding current trading prices, 6821.HK is priced at HK$74.40, while 1228.HK trades at HK$0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6821.HK currently has a P/E ratio of 24.16, whereas 1228.HK's P/E ratio is -0.27. In terms of profitability, 6821.HK's ROE is +0.06%, compared to 1228.HK's ROE of +1.17%. Regarding short-term risk, 6821.HK is less volatile compared to 1228.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6821.HK.